Bioanalytical Syst (BASI) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:BASI

16.44
+1.42 (+9.45%)
At close: Mar 19, 2021
15.65
-0.79 (-4.81%)
After Hours: 3/19/2021, 8:23:38 PM

BASI Key Statistics, Chart & Performance

Key Statistics
Market Cap182.99M
Revenue(TTM)65.44M
Net Income(TTM)-3.63M
Shares11.13M
Float8.55M
52 Week High21.08
52 Week Low3.05
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.32
PEN/A
Fwd PE182.67
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
BASI short term performance overview.The bars show the price performance of BASI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150 200

BASI long term performance overview.The bars show the price performance of BASI in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300 400

The current stock price of BASI is 16.44 null. In the past month the price increased by 4.51%. In the past year, price increased by 415.36%.

Bioanalytical Syst / BASI Daily stock chart

BASI Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to BASI. When comparing the yearly performance of all stocks, BASI is one of the better performing stocks in the market, outperforming 96.63% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BASI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to BASI. Both the profitability and financial health of BASI have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BASI Financial Highlights

Over the last trailing twelve months BASI reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS decreased by -190.91% compared to the year before.


Industry RankSector Rank
PM (TTM) -5.54%
ROA -5.77%
ROE N/A
Debt/Equity 2.31
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%38.45%
EPS 1Y (TTM)-190.91%
Revenue 1Y (TTM)36.58%

BASI Forecast & Estimates


Analysts
Analysts80
Price TargetN/A
EPS Next Y40%
Revenue Next YearN/A

BASI Ownership

Ownership
Inst Owners15.86%
Ins Owners14.77%
Short Float %N/A
Short RatioN/A

About BASI

Company Profile

Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.

Company Info

Bioanalytical Syst

2701 KENT AVENUE

WEST LAFAYETTE IN 47906

CEO: Robert W. Leasure Jr.

Phone: 765-463-4527

Bioanalytical Syst / BASI FAQ

Can you describe the business of Bioanalytical Syst?

Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.


What is the current price of BASI stock?

The current stock price of BASI is 16.44 null. The price increased by 9.45% in the last trading session.


What is the dividend status of Bioanalytical Syst?

BASI does not pay a dividend.


What is the ChartMill technical and fundamental rating of BASI stock?

BASI has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


How is the valuation of Bioanalytical Syst (BASI) based on its PE ratio?

Bioanalytical Syst (BASI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.32).


Should I buy BASI stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BASI.